Renalytix uses cookies to improve your experience. We respect your privacy and are committed to protecting your personal data. Read Privacy Notice.
Investors kidneyintelX.dkd

About renalytixprod

This author has not yet filled in any details.
So far renalytixprod has created 112 blog entries.

RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX™ for Diagnosing Fast-Progressing Kidney Disease

Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigators NEW YORK, Jan. 23, 2019 /PRNewswire/ --  Renalytix AI plc  (LON: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced


Read More
By |2019-01-23T00:00:00+00:0001.23.19|News|0 Comments
Go to Top